<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2017-12-20" version="205">
<accession>P11509</accession>
<accession>A7YAE5</accession>
<accession>B2R7F6</accession>
<accession>P00190</accession>
<accession>P10890</accession>
<accession>Q16803</accession>
<accession>Q4VAT9</accession>
<accession>Q4VAU0</accession>
<accession>Q4VAU1</accession>
<accession>Q9H1Z7</accession>
<accession>Q9UCU0</accession>
<accession>Q9UK48</accession>
<name>CP2A6_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cytochrome P450 2A6</fullName>
<ecNumber>1.14.13.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>1,4-cineole 2-exo-monooxygenase</fullName>
</alternativeName>
<alternativeName>
<fullName>CYPIIA6</fullName>
</alternativeName>
<alternativeName>
<fullName>Coumarin 7-hydroxylase</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytochrome P450 IIA3</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytochrome P450(I)</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CYP2A6</name>
<name type="synonym">CYP2A3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="Nucleic Acids Res." volume="17" first="2907" last="2917">
<title>Close linkage of the human cytochrome P450IIA and P450IIB gene subfamilies: implications for the assignment of substrate specificity.</title>
<authorList>
<person name="Miles J.S."/>
<person name="Bickmore W."/>
<person name="Brook J.D."/>
<person name="McLaren A.W."/>
<person name="Meehan R."/>
<person name="Wolf C.R."/>
</authorList>
<dbReference type="PubMed" id="2726448"/>
<dbReference type="DOI" id="10.1093/nar/17.8.2907"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS ASN-29 AND TYR-392</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="Nucleic Acids Res." volume="17" first="4888" last="4888">
<title>cDNA and deduced amino acid sequences of human P450 IIA3 (CYP2A3).</title>
<authorList>
<person name="Yamano S."/>
<person name="Nagata K."/>
<person name="Yamazoe Y."/>
<person name="Kato R."/>
<person name="Gelboin H.V."/>
<person name="Gonzalez F.J."/>
</authorList>
<dbReference type="PubMed" id="2748347"/>
<dbReference type="DOI" id="10.1093/nar/17.12.4888"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS HIS-160 AND TYR-392</scope>
<source>
<tissue>Hepatocyte</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1990" name="Biochemistry" volume="29" first="1322" last="1329">
<title>The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.</title>
<authorList>
<person name="Yamano S."/>
<person name="Tatsuno J."/>
<person name="Gonzalez F.J."/>
</authorList>
<dbReference type="PubMed" id="2322567"/>
<dbReference type="DOI" id="10.1021/bi00457a031"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS HIS-160 AND TYR-392</scope>
<scope>CHARACTERIZATION OF VARIANT HIS-160</scope>
<source>
<tissue>Hepatocyte</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="1999-09" db="EMBL/GenBank/DDBJ databases">
<title>Sequence of a new human cytochrome P450-2A6 cDNA.</title>
<authorList>
<person name="Zhuge J."/>
<person name="Qian Y."/>
<person name="Xie H."/>
<person name="Yu Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT TYR-392</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT TYR-392</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2007-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS HIS-160; CYS-203; MET-365; TYR-392; ASP-418 AND ASP-419</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT TYR-392</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS HIS-160; TYR-392 AND ARG-476</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1991" name="Eur. J. Biochem." volume="200" first="511" last="517">
<title>Isolation and characterization of a cytochrome P450 of the IIA subfamily from human liver microsomes.</title>
<authorList>
<person name="Maurice M."/>
<person name="Emiliani S."/>
<person name="Dalet-Beluche I."/>
<person name="Derancourt J."/>
<person name="Lange R."/>
</authorList>
<dbReference type="PubMed" id="1889415"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1991.tb16212.x"/>
</citation>
<scope>PROTEIN SEQUENCE OF 1-20</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1991" name="Mol. Pharmacol." volume="40" first="679" last="685">
<title>Purification and characterization of human liver microsomal cytochrome P-450 2A6.</title>
<authorList>
<person name="Yun C.H."/>
<person name="Shimada T."/>
<person name="Guengerich F.P."/>
</authorList>
<dbReference type="PubMed" id="1944238"/>
</citation>
<scope>PROTEIN SEQUENCE OF 1-13</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="17830" last="17835">
<title>CYP2A6*6, a novel polymorphism in cytochrome p450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity.</title>
<authorList>
<person name="Kitagawa K."/>
<person name="Kunugita N."/>
<person name="Kitagawa M."/>
<person name="Kawamoto T."/>
</authorList>
<dbReference type="PubMed" id="11278503"/>
<dbReference type="DOI" id="10.1074/jbc.M009432200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 116-164</scope>
<scope>VARIANT CYP2A6*6 GLN-128</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1985" name="Proc. Natl. Acad. Sci. U.S.A." volume="82" first="983" last="987">
<title>Isolation and sequence of a human cytochrome P-450 cDNA clone.</title>
<authorList>
<person name="Phillips I.R."/>
<person name="Shephard E.A."/>
<person name="Ashworth A."/>
<person name="Rabin B.R."/>
</authorList>
<dbReference type="PubMed" id="3856261"/>
<dbReference type="DOI" id="10.1073/pnas.82.4.983"/>
</citation>
<scope>PRELIMINARY NUCLEOTIDE SEQUENCE [MRNA] OF 163-494</scope>
<scope>VARIANT TYR-392</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="Xenobiotica" volume="31" first="713" last="723">
<title>Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes.</title>
<authorList>
<person name="Miyazawa M."/>
<person name="Shindo M."/>
<person name="Shimada T."/>
</authorList>
<dbReference type="PubMed" id="11695850"/>
<dbReference type="DOI" id="10.1080/00498250110065595"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION AS 1,4-CINEOLE 2-EXO-MONOOXYGENASE</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="Nat. Struct. Mol. Biol." volume="12" first="822" last="823">
<title>Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen.</title>
<authorList>
<person name="Yano J.K."/>
<person name="Hsu M.H."/>
<person name="Griffin K.J."/>
<person name="Stout C.D."/>
<person name="Johnson E.F."/>
</authorList>
<dbReference type="PubMed" id="16086027"/>
<dbReference type="DOI" id="10.1038/nsmb971"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 29-494 IN COMPLEX WITH COUMARIN; HEME AND THE INHIBITOR METHOXSALEN</scope>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="J. Med. Chem." volume="49" first="6987" last="7001">
<title>Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.</title>
<authorList>
<person name="Yano J.K."/>
<person name="Denton T.T."/>
<person name="Cerny M.A."/>
<person name="Zhang X."/>
<person name="Johnson E.F."/>
<person name="Cashman J.R."/>
</authorList>
<dbReference type="PubMed" id="17125252"/>
<dbReference type="DOI" id="10.1021/jm060519r"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 29-494 IN COMPLEX WITH PHENACETIN AND HEME</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Drug Metab. Dispos." volume="36" first="2582" last="2590">
<title>Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes.</title>
<authorList>
<person name="DeVore N.M."/>
<person name="Smith B.D."/>
<person name="Urban M.J."/>
<person name="Scott E.E."/>
</authorList>
<dbReference type="PubMed" id="18779312"/>
<dbReference type="DOI" id="10.1124/dmd.108.023770"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 29-494 IN COMPLEX WITH PHENACETIN AND HEME</scope>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANTS LEU-110 AND MET-365</scope>
<scope>MUTAGENESIS OF ILE-208; SER-213; ILE-300; GLY-301; SER-369 AND ARG-372</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1997" name="Food Chem. Toxicol." volume="35" first="903" last="907">
<title>A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin.</title>
<authorList>
<person name="Hadidi H."/>
<person name="Zahlsen K."/>
<person name="Idle J.R."/>
<person name="Cholerton S."/>
</authorList>
<dbReference type="PubMed" id="9409631"/>
<dbReference type="DOI" id="10.1016/S0278-6915(97)00066-5"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT CYP2A6*2 HIS-160</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1999" name="FEBS Lett." volume="460" first="321" last="327">
<title>Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.</title>
<authorList>
<person name="Oscarson M."/>
<person name="McLellan R.A."/>
<person name="Gullsten H."/>
<person name="Agundez J.A."/>
<person name="Benitez J."/>
<person name="Rautio A."/>
<person name="Raunio H."/>
<person name="Pelkonen O."/>
<person name="Ingelman-Sundberg M."/>
</authorList>
<dbReference type="PubMed" id="10544257"/>
<dbReference type="DOI" id="10.1016/S0014-5793(99)01364-2"/>
</citation>
<scope>VARIANT CYP2A6*5 VAL-479</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="281" first="810" last="814">
<title>A novel single nucleotide polymorphism altering stability and activity of CYP2a6.</title>
<authorList>
<person name="Ariyoshi N."/>
<person name="Sawamura Y."/>
<person name="Kamataki T."/>
</authorList>
<dbReference type="PubMed" id="11237731"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.4422"/>
</citation>
<scope>VARIANTS CYP2A6*7 THR-471 AND CYP2A6*8 LEU-485</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="Drug Metab. Pharmacokinet." volume="17" first="482" last="487">
<title>Twenty one novel single nucleotide polymorphisms (SNPs) of the CYP2A6 gene in Japanese and Caucasians.</title>
<authorList>
<person name="Kiyotani K."/>
<person name="Fujieda M."/>
<person name="Yamazaki H."/>
<person name="Shimada T."/>
<person name="Guengerich F.P."/>
<person name="Parkinson A."/>
<person name="Nakagawa K."/>
<person name="Ishizaki T."/>
<person name="Kamataki T."/>
</authorList>
<dbReference type="PubMed" id="15618701"/>
<dbReference type="DOI" id="10.2133/dmpk.17.482"/>
</citation>
<scope>VARIANTS CYP2A6*13 ARG-5; CYP2A6*14 ASN-29; CYP2A6*15 GLU-194 AND CYP2A6*16 SER-203</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="J. Hum. Genet." volume="48" first="249" last="270">
<title>Catalog of 680 variations among eight cytochrome p450 (CYP) genes, nine esterase genes, and two other genes in the Japanese population.</title>
<authorList>
<person name="Saito S."/>
<person name="Iida A."/>
<person name="Sekine A."/>
<person name="Kawauchi S."/>
<person name="Higuchi S."/>
<person name="Ogawa C."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="12721789"/>
<dbReference type="DOI" id="10.1007/s10038-003-0021-7"/>
</citation>
<scope>VARIANTS ASP-419 AND THR-471</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Pharmacogenomics" volume="5" first="895" last="931">
<title>Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.</title>
<authorList>
<person name="Solus J.F."/>
<person name="Arietta B.J."/>
<person name="Harris J.R."/>
<person name="Sexton D.P."/>
<person name="Steward J.Q."/>
<person name="McMunn C."/>
<person name="Ihrie P."/>
<person name="Mehall J.M."/>
<person name="Edwards T.L."/>
<person name="Dawson E.P."/>
</authorList>
<dbReference type="PubMed" id="15469410"/>
<dbReference type="DOI" id="10.1517/14622416.5.7.895"/>
</citation>
<scope>VARIANTS ARG-5; ASN-29; LEU-118; GLN-128; PRO-224; MET-365; ASP-418; ASP-419; THR-471; ARG-476 AND LEU-485</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Hum. Mutat." volume="29" first="679" last="688">
<title>Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent.</title>
<authorList>
<person name="Mwenifumbo J.C."/>
<person name="Al Koudsi N."/>
<person name="Ho M.K."/>
<person name="Zhou Q."/>
<person name="Hoffmann E.B."/>
<person name="Sellers E.M."/>
<person name="Tyndale R.F."/>
</authorList>
<dbReference type="PubMed" id="18360915"/>
<dbReference type="DOI" id="10.1002/humu.20698"/>
</citation>
<scope>VARIANTS LEU-110; LEU-118; LEU-128; ALA-131; ASP-418; ASP-419 AND TYR-438</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Pharmacogenet. Genomics" volume="18" first="67" last="75">
<title>A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent.</title>
<authorList>
<person name="Ho M.K."/>
<person name="Mwenifumbo J.C."/>
<person name="Zhao B."/>
<person name="Gillam E.M."/>
<person name="Tyndale R.F."/>
</authorList>
<dbReference type="PubMed" id="18216723"/>
<dbReference type="DOI" id="10.1097/FPC.0b013e3282f3606e"/>
</citation>
<scope>VARIANTS CYS-203; SER-203 AND MET-365</scope>
<scope>CHARACTERIZATION OF VARIANT CYS-203</scope>
</reference>
<comment type="function">
<text evidence="11 17 18 21 22 23">Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Constitutes the major nicotine C-oxidase. Acts as a 1,4-cineole 2-exo-monooxygenase. Possesses low phenacetin O-deethylation activity.</text>
</comment>
<comment type="catalytic activity">
<text evidence="11">1,4-cineole + NADPH + O(2) = 2-exo-hydroxy-1,4-cineole + NADP(+) + H(2)O.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>heme</name>
<dbReference type="ChEBI" id="CHEBI:30413"/>
</cofactor>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="11 17">0.23 uM for coumarin</KM>
<KM evidence="11 17">530 uM for 1,4-cineole</KM>
<Vmax evidence="11 17">3.5 nmol/min/nmol enzyme toward 2-exo-hydroxy-1,4-cineole</Vmax>
</kinetics>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Endoplasmic reticulum membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Microsome membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="22 23">Liver.</text>
</comment>
<comment type="induction">
<text evidence="22 23">By phenobarbital and dexamethasone.</text>
</comment>
<comment type="similarity">
<text evidence="32">Belongs to the cytochrome P450 family.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAA52147" version="1"/>
</conflict>
<text>Numerous conflicts and frameshifts.</text>
</comment>
<comment type="online information" name="Cytochrome P450 Allele Nomenclature Committee">
<link uri="http://www.cypalleles.ki.se/cyp2a6.htm"/>
<text>CYP2A6 alleles</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/cyp2a6/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/CYP2A6"/>
<text>CYP2A6 entry</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CYP2A6ID40240ch19q13.html"/>
</comment>
<dbReference type="EC" id="1.14.13.-"/>
<dbReference type="EMBL" id="X13897">
<property type="protein sequence ID" value="CAA32097.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X13929">
<property type="protein sequence ID" value="CAA32117.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X13930">
<property type="protein sequence ID" value="CAA32118.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M33318">
<property type="protein sequence ID" value="AAA52067.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF182275">
<property type="protein sequence ID" value="AAF13600.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312964">
<property type="protein sequence ID" value="BAG35803.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU135979">
<property type="protein sequence ID" value="ABV02584.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ440681">
<property type="protein sequence ID" value="ACK44068.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC008537">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471126">
<property type="protein sequence ID" value="EAW57012.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC096253">
<property type="protein sequence ID" value="AAH96253.3"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC096254">
<property type="protein sequence ID" value="AAH96254.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC096255">
<property type="protein sequence ID" value="AAH96255.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC096256">
<property type="protein sequence ID" value="AAH96256.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF326721">
<property type="protein sequence ID" value="AAG45229.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="K03192">
<property type="protein sequence ID" value="AAA52147.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12568.1"/>
<dbReference type="PIR" id="A00190">
<property type="entry name" value="O4HUPB"/>
</dbReference>
<dbReference type="PIR" id="S04698">
<property type="entry name" value="O4HUA6"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000753.3">
<property type="nucleotide sequence ID" value="NM_000762.5"/>
</dbReference>
<dbReference type="UniGene" id="Hs.250615"/>
<dbReference type="PDB" id="1Z10">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B/C/D=29-494"/>
</dbReference>
<dbReference type="PDB" id="1Z11">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A/B/C/D=29-494"/>
</dbReference>
<dbReference type="PDB" id="2FDU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B/C/D=29-494"/>
</dbReference>
<dbReference type="PDB" id="2FDV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/B/C/D=29-494"/>
</dbReference>
<dbReference type="PDB" id="2FDW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A/B/C/D=29-494"/>
</dbReference>
<dbReference type="PDB" id="2FDY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B/C/D=29-494"/>
</dbReference>
<dbReference type="PDB" id="3EBS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B/C/D=29-494"/>
</dbReference>
<dbReference type="PDB" id="3T3Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B/C/D=29-494"/>
</dbReference>
<dbReference type="PDB" id="3T3R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=29-494"/>
</dbReference>
<dbReference type="PDB" id="4EJJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=29-494"/>
</dbReference>
<dbReference type="PDB" id="4RUI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.61"/>
<property type="chains" value="A/B/C/D/E/F=29-494"/>
</dbReference>
<dbReference type="PDBsum" id="1Z10"/>
<dbReference type="PDBsum" id="1Z11"/>
<dbReference type="PDBsum" id="2FDU"/>
<dbReference type="PDBsum" id="2FDV"/>
<dbReference type="PDBsum" id="2FDW"/>
<dbReference type="PDBsum" id="2FDY"/>
<dbReference type="PDBsum" id="3EBS"/>
<dbReference type="PDBsum" id="3T3Q"/>
<dbReference type="PDBsum" id="3T3R"/>
<dbReference type="PDBsum" id="4EJJ"/>
<dbReference type="PDBsum" id="4RUI"/>
<dbReference type="ProteinModelPortal" id="P11509"/>
<dbReference type="SMR" id="P11509"/>
<dbReference type="BioGrid" id="107927">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000301141"/>
<dbReference type="BindingDB" id="P11509"/>
<dbReference type="ChEMBL" id="CHEMBL5282"/>
<dbReference type="DrugBank" id="DB07621">
<property type="generic name" value="(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB04665">
<property type="generic name" value="2H-1-BENZOPYRAN-2-ONE"/>
</dbReference>
<dbReference type="DrugBank" id="DB00316">
<property type="generic name" value="Acetaminophen"/>
</dbReference>
<dbReference type="DrugBank" id="DB01118">
<property type="generic name" value="Amiodarone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00381">
<property type="generic name" value="Amlodipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01351">
<property type="generic name" value="Amobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB00182">
<property type="generic name" value="Amphetamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01435">
<property type="generic name" value="Antipyrine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01274">
<property type="generic name" value="Arformoterol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00972">
<property type="generic name" value="Azelastine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00207">
<property type="generic name" value="Azithromycin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00921">
<property type="generic name" value="Buprenorphine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01156">
<property type="generic name" value="Bupropion"/>
</dbReference>
<dbReference type="DrugBank" id="DB00356">
<property type="generic name" value="Chlorzoxazone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00568">
<property type="generic name" value="Cinnarizine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00604">
<property type="generic name" value="Cisapride"/>
</dbReference>
<dbReference type="DrugBank" id="DB00636">
<property type="generic name" value="Clofibrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00882">
<property type="generic name" value="Clomifene"/>
</dbReference>
<dbReference type="DrugBank" id="DB00257">
<property type="generic name" value="Clotrimazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00363">
<property type="generic name" value="Clozapine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00531">
<property type="generic name" value="Cyclophosphamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB06292">
<property type="generic name" value="Dapagliflozin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01151">
<property type="generic name" value="Desipramine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01234">
<property type="generic name" value="Dexamethasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01191">
<property type="generic name" value="Dexfenfluramine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00255">
<property type="generic name" value="Diethylstilbestrol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00470">
<property type="generic name" value="Dronabinol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00216">
<property type="generic name" value="Eletriptan"/>
</dbReference>
<dbReference type="DrugBank" id="DB04953">
<property type="generic name" value="Ezogabine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04841">
<property type="generic name" value="Flunarizine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01544">
<property type="generic name" value="Flunitrazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00544">
<property type="generic name" value="Fluorouracil"/>
</dbReference>
<dbReference type="DrugBank" id="DB00690">
<property type="generic name" value="Flurazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01213">
<property type="generic name" value="Fomepizole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00983">
<property type="generic name" value="Formoterol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01159">
<property type="generic name" value="Halothane"/>
</dbReference>
<dbReference type="DrugBank" id="DB01181">
<property type="generic name" value="Ifosfamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00951">
<property type="generic name" value="Isoniazid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01026">
<property type="generic name" value="Ketoconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB01006">
<property type="generic name" value="Letrozole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00281">
<property type="generic name" value="Lidocaine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04871">
<property type="generic name" value="Lorcaserin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01043">
<property type="generic name" value="Memantine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00170">
<property type="generic name" value="Menadione"/>
</dbReference>
<dbReference type="DrugBank" id="DB00763">
<property type="generic name" value="Methimazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00553">
<property type="generic name" value="Methoxsalen"/>
</dbReference>
<dbReference type="DrugBank" id="DB01028">
<property type="generic name" value="Methoxyflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB01011">
<property type="generic name" value="Metyrapone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01110">
<property type="generic name" value="Miconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00471">
<property type="generic name" value="Montelukast"/>
</dbReference>
<dbReference type="DrugBank" id="DB07617">
<property type="generic name" value="N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB00238">
<property type="generic name" value="Nevirapine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00184">
<property type="generic name" value="Nicotine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01115">
<property type="generic name" value="Nifedipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB06712">
<property type="generic name" value="Nilvadipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01059">
<property type="generic name" value="Norfloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00312">
<property type="generic name" value="Pentobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB03783">
<property type="generic name" value="Phenacetin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01174">
<property type="generic name" value="Phenobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB01085">
<property type="generic name" value="Pilocarpine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04977">
<property type="generic name" value="Plitidepsin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00860">
<property type="generic name" value="Prednisolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00396">
<property type="generic name" value="Progesterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00818">
<property type="generic name" value="Propofol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01045">
<property type="generic name" value="Rifampicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00412">
<property type="generic name" value="Rosiglitazone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01037">
<property type="generic name" value="Selegiline"/>
</dbReference>
<dbReference type="DrugBank" id="DB01236">
<property type="generic name" value="Sevoflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB06729">
<property type="generic name" value="Sulfaphenazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00675">
<property type="generic name" value="Tamoxifen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00752">
<property type="generic name" value="Tranylcypromine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00755">
<property type="generic name" value="Tretinoin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01361">
<property type="generic name" value="Troleandomycin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00313">
<property type="generic name" value="Valproic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB09068">
<property type="generic name" value="Vortioxetine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00495">
<property type="generic name" value="Zidovudine"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1321"/>
<dbReference type="iPTMnet" id="P11509"/>
<dbReference type="PhosphoSitePlus" id="P11509"/>
<dbReference type="BioMuta" id="CYP2A6"/>
<dbReference type="DMDM" id="308153612"/>
<dbReference type="PaxDb" id="P11509"/>
<dbReference type="PeptideAtlas" id="P11509"/>
<dbReference type="PRIDE" id="P11509"/>
<dbReference type="DNASU" id="1548"/>
<dbReference type="Ensembl" id="ENST00000301141">
<property type="protein sequence ID" value="ENSP00000301141"/>
<property type="gene ID" value="ENSG00000255974"/>
</dbReference>
<dbReference type="GeneID" id="1548"/>
<dbReference type="KEGG" id="hsa:1548"/>
<dbReference type="UCSC" id="uc002opl.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1548"/>
<dbReference type="DisGeNET" id="1548"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000255974.6"/>
<dbReference type="GeneCards" id="CYP2A6"/>
<dbReference type="HGNC" id="HGNC:2610">
<property type="gene designation" value="CYP2A6"/>
</dbReference>
<dbReference type="HPA" id="HPA046713"/>
<dbReference type="HPA" id="HPA047262"/>
<dbReference type="MalaCards" id="CYP2A6"/>
<dbReference type="MIM" id="122720">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P11509"/>
<dbReference type="PharmGKB" id="PA121"/>
<dbReference type="eggNOG" id="KOG0156">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG2124">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOVERGEN" id="HBG015789"/>
<dbReference type="InParanoid" id="P11509"/>
<dbReference type="KO" id="K17683"/>
<dbReference type="PhylomeDB" id="P11509"/>
<dbReference type="TreeFam" id="TF352043"/>
<dbReference type="BioCyc" id="MetaCyc:HS10343-MONOMER"/>
<dbReference type="BRENDA" id="1.14.14.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211981">
<property type="pathway name" value="Xenobiotics"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211999">
<property type="pathway name" value="CYP2E1 reactions"/>
</dbReference>
<dbReference type="SABIO-RK" id="P11509"/>
<dbReference type="EvolutionaryTrace" id="P11509"/>
<dbReference type="GeneWiki" id="CYP2A6"/>
<dbReference type="GenomeRNAi" id="1548"/>
<dbReference type="PRO" id="PR:P11509"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000255974"/>
<dbReference type="ExpressionAtlas" id="P11509">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P11509">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005881">
<property type="term" value="C:cytoplasmic microtubule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031090">
<property type="term" value="C:organelle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0008392">
<property type="term" value="F:arachidonic acid epoxygenase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008389">
<property type="term" value="F:coumarin 7-hydroxylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0020037">
<property type="term" value="F:heme binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005506">
<property type="term" value="F:iron ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0016712">
<property type="term" value="F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0008395">
<property type="term" value="F:steroid hydroxylase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046226">
<property type="term" value="P:coumarin catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009804">
<property type="term" value="P:coumarin metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017144">
<property type="term" value="P:drug metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019373">
<property type="term" value="P:epoxygenase P450 pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042738">
<property type="term" value="P:exogenous drug catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008202">
<property type="term" value="P:steroid metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.630.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001128">
<property type="entry name" value="Cyt_P450"/>
</dbReference>
<dbReference type="InterPro" id="IPR017972">
<property type="entry name" value="Cyt_P450_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002401">
<property type="entry name" value="Cyt_P450_E_grp-I"/>
</dbReference>
<dbReference type="InterPro" id="IPR008067">
<property type="entry name" value="Cyt_P450_E_grp-I_CYP2A-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR036396">
<property type="entry name" value="Cyt_P450_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00067">
<property type="entry name" value="p450"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00463">
<property type="entry name" value="EP450I"/>
</dbReference>
<dbReference type="PRINTS" id="PR01684">
<property type="entry name" value="EP450ICYP2A"/>
</dbReference>
<dbReference type="PRINTS" id="PR00385">
<property type="entry name" value="P450"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48264">
<property type="entry name" value="SSF48264"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00086">
<property type="entry name" value="CYTOCHROME_P450"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0349">Heme</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0492">Microsome</keyword>
<keyword id="KW-0503">Monooxygenase</keyword>
<keyword id="KW-0521">NADP</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="chain" description="Cytochrome P450 2A6" id="PRO_0000051668">
<location>
<begin position="1"/>
<end position="494"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron (heme axial ligand)">
<location>
<position position="439"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="32">
<location>
<position position="107"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="297"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="131"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*13; dbSNP:rs28399434." id="VAR_018330" evidence="14 16">
<original>G</original>
<variation>R</variation>
<location>
<position position="5"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*14; dbSNP:rs28399435." id="VAR_018331" evidence="14 16 25">
<original>S</original>
<variation>N</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*24; increases phenacetin O-deethylation activity 4 fold; dbSNP:rs72549435." id="VAR_055035" evidence="20 21">
<original>V</original>
<variation>L</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*25 and allele CYP2A6*26; dbSNP:rs28399440." id="VAR_024711" evidence="14 20">
<original>F</original>
<variation>L</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*26." id="VAR_055036" evidence="20">
<original>R</original>
<variation>L</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*6; loss of activity; dbSNP:rs4986891." id="VAR_011577" evidence="10 14">
<original>R</original>
<variation>Q</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*26; dbSNP:rs59552350." id="VAR_055037" evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*2; unable to catalyze 7-hydroxylation of coumarin; causes switching from coumarin 7-hydroxylation to 3-hydroxylation; dbSNP:rs1801272." id="VAR_001249" evidence="15 24 26 28 30">
<original>L</original>
<variation>H</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*15." id="VAR_018332" evidence="16">
<original>K</original>
<variation>E</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*23; greatly reduced activity toward nicotine C-oxidation as well as reduced coumarin 7-hydroxylation; dbSNP:rs56256500." id="VAR_055034" evidence="19 30">
<original>R</original>
<variation>C</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*16; dbSNP:rs56256500." id="VAR_018333" evidence="16 19">
<original>R</original>
<variation>S</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28399447." id="VAR_024712" evidence="14">
<original>S</original>
<variation>P</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2644906." id="VAR_059149">
<original>V</original>
<variation>M</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4997557." id="VAR_048448">
<original>T</original>
<variation>S</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*17; increases phenacetin O-deethylation activity 2 fold; dbSNP:rs28399454." id="VAR_024713" evidence="14 19 21 30">
<original>V</original>
<variation>M</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1809810." id="VAR_055033" evidence="13 15 24 25 26 27 29 30 31">
<original>F</original>
<variation>Y</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*28; dbSNP:rs28399463." id="VAR_024714" evidence="14 20 30">
<original>N</original>
<variation>D</variation>
<location>
<position position="418"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*28; dbSNP:rs8192730." id="VAR_018375" evidence="12 14 20 30">
<original>E</original>
<variation>D</variation>
<location>
<position position="419"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*24." id="VAR_055038" evidence="20">
<original>N</original>
<variation>Y</variation>
<location>
<position position="438"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*7; dbSNP:rs5031016." id="VAR_011578" evidence="9 12 14">
<original>I</original>
<variation>T</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6413474." id="VAR_024715" evidence="14 15">
<original>K</original>
<variation>R</variation>
<location>
<position position="476"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*5; loss of activity; dbSNP:rs5031017." id="VAR_008356" evidence="8">
<original>G</original>
<variation>V</variation>
<location>
<position position="479"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A6*8; dbSNP:rs28399468." id="VAR_011579" evidence="9 14">
<original>R</original>
<variation>L</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases phenacetin O-deethylation activity 10 fold; when associated with F-300 and A-301. Increases phenacetin O-deethylation activity 38 fold; when associated with F-300; A-301 and G-369." evidence="21">
<original>I</original>
<variation>S</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phenacetin O-deethylation activity." evidence="21">
<original>S</original>
<variation>A</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases phenacetin O-deethylation activity 3 fold. Increases phenacetin O-deethylation activity 8 fold; when associated with A-301. Increases phenacetin O-deethylation activity 10 fold; when associated with S-208 and A-301. Increases phenacetin O-deethylation activity 12 fold; when associated with A-301 and G-369. Increases phenacetin O-deethylation activity 38 fold; when associated with S-208; A-301 and G-369." evidence="21">
<original>I</original>
<variation>F</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly decreases phenacetin O-deethylation activity. Increases phenacetin O-deethylation activity 8 fold; when associated with F-300. Increases phenacetin O-deethylation activity 10 fold; when associated with S-208 and F-300. Increases phenacetin O-deethylation activity 12 fold; when associated with F-300 and G-369. Increases phenacetin O-deethylation activity 38 fold; when associated with S-208; F-300 and G-369." evidence="21">
<original>G</original>
<variation>A</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases phenacetin O-deethylation activity 3 fold. Increases phenacetin O-deethylation activity 38 fold; when associated with S-208; F-300 and A-301." evidence="21">
<original>S</original>
<variation>G</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases phenacetin O-deethylation activity 2 fold." evidence="21">
<original>R</original>
<variation>H</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA32097." ref="1" evidence="32">
<location>
<begin position="3"/>
<end position="7"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA32097." ref="1" evidence="32">
<original>N</original>
<variation>K</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA32097." ref="1" evidence="32">
<original>K</original>
<variation>Q</variation>
<location>
<position position="326"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="41"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="46"/>
<end position="48"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="51"/>
<end position="53"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="54"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="67"/>
<end position="73"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="76"/>
<end position="81"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="84"/>
<end position="91"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="92"/>
<end position="98"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="105"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="115"/>
<end position="118"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="121"/>
<end position="137"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="138"/>
<end position="141"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="143"/>
<end position="162"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="171"/>
<end position="187"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="196"/>
<end position="212"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="215"/>
<end position="227"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="230"/>
<end position="232"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="233"/>
<end position="256"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="267"/>
<end position="277"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="278"/>
<end position="280"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="288"/>
<end position="319"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="321"/>
<end position="334"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="337"/>
<end position="339"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="343"/>
<end position="348"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="350"/>
<end position="363"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="378"/>
<end position="380"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="383"/>
<end position="385"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="390"/>
<end position="393"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="395"/>
<end position="399"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="402"/>
<end position="404"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="405"/>
<end position="407"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="413"/>
<end position="416"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="419"/>
<end position="421"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="442"/>
<end position="459"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="460"/>
<end position="466"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="468"/>
<end position="470"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="476"/>
<end position="483"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="489"/>
<end position="493"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2FDU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2FDV"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2FDY"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3T3Q"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RUI"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P00176"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q64458"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10544257"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11237731"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11278503"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11695850"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12721789"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15469410"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15618701"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16086027"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17125252"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18216723"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18360915"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18779312"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1889415"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1944238"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2322567"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2726448"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2748347"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3856261"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9409631"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="30" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="31" type="ECO:0000269">
<source ref="8"/>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<sequence length="494" mass="56501" checksum="8C05CBF0EFC698AF" modified="2010-10-05" version="3">
MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMK
ISERYGPVFTIHLGPRRVVVLCGHDAVREALVDQAEEFSGRGEQATFDWVFKGYGVVFSN
GERAKQLRRFSIATLRDFGVGKRGIEERIQEEAGFLIDALRGTGGANIDPTFFLSRTVSN
VISSIVFGDRFDYKDKEFLSLLRMMLGIFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQL
LQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFI
GGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQ
RFGDVIPMSLARRVKKDTKFRDFFLPKGTEVFPMLGSVLRDPSFFSNPQDFNPQHFLNEK
GQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGF
ATIPRNYTMSFLPR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>